These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 8553293)

  • 1. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
    Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
    Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association?
    Vergnon JM; Vincent M; de Thé G; Mornex JF; Weynants P; Brune J
    Lancet; 1984 Oct; 2(8406):768-71. PubMed ID: 6148520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and cryptogenic fibrosing alveolitis.
    Hogg JC
    Thorax; 1995 Dec; 50(12):1232. PubMed ID: 8553292
    [No Abstract]   [Full Text] [Related]  

  • 4. Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection.
    Wangoo A; Shaw RJ; Diss TC; Farrell PJ; du Bois RM; Nicholson AG
    Thorax; 1997 Oct; 52(10):888-91. PubMed ID: 9404376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
    Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
    Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis.
    Stewart JP; Egan JJ; Ross AJ; Kelly BG; Lok SS; Hasleton PS; Woodcock AA
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1336-41. PubMed ID: 10194186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
    Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
    Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis.
    Nash JR; McLaughlin PJ; Butcher D; Corrin B
    Histopathology; 1993 Apr; 22(4):343-7. PubMed ID: 8514277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.
    Wallace WA; Schofield JA; Lamb D; Howie SE
    Thorax; 1994 Nov; 49(11):1139-45. PubMed ID: 7831631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
    al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
    Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr-virus-induced interstitial lung disease.
    Marzouk K; Corate L; Saleh S; Sharma OP
    Curr Opin Pulm Med; 2005 Sep; 11(5):456-60. PubMed ID: 16093822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity.
    Matsuyama W; Kawabata M; Mizoguchi A; Iwami F; Wakimoto J; Osame M
    Clin Exp Immunol; 2003 Sep; 133(3):397-403. PubMed ID: 12930367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
    Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung injury associated with severe Epstein-Barr virus (EBV) infection].
    Cui Y; Zhang Y; Wang F; Zhu Y; Chen R; Xu L
    Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):586-91. PubMed ID: 26717656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.
    Campbell DA; Poulter LW; Janossy G; du Bois RM
    Thorax; 1985 Jun; 40(6):405-11. PubMed ID: 3875162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar macrophage lysosomal enzyme and C3b receptors in cryptogenic fibrosing alveolitis.
    du Bois RM; Townsend PJ; Cole PJ
    Clin Exp Immunol; 1980 Apr; 40(1):60-5. PubMed ID: 7389217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis.
    Kirk JM; Heard BE; Kerr I; Turner-Warwick M; Laurent GJ
    Coll Relat Res; 1984 May; 4(3):169-82. PubMed ID: 6205817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China.
    Han AJ; Xiong M; Zong YS
    Am J Clin Pathol; 2000 Aug; 114(2):220-6. PubMed ID: 10941337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis.
    Johnston ID; Bleasdale C; Hind CR; Woodcock AA
    Thorax; 1991 Aug; 46(8):589-91. PubMed ID: 1926030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.